Related Experiment Videos
Cyclin D1 overexpression in hepatocellular carcinoma
1Department of Pathology, Inje University Seoul Paik Hospital, Seoul, Korea.
Liver
|April 25, 2001
Summary
Cyclin D1 overexpression is common in hepatocellular carcinoma (HCC) and may indicate early tumor development. Its expression is linked to tumor differentiation but not cell proliferation, unlike p53.
Area of Science:
- Hepatocellular Carcinoma Research
- Oncology Biomarkers
- Molecular Pathology
Background:
- Cyclin D1 gene amplification and protein overexpression are observed in various human tumors.
- The role of cyclin D1 in hepatocellular carcinoma (HCC) remains controversial.
- This study investigates cyclin D1 expression and its correlation with p53 and Ki-67 in HCC.
Purpose of the Study:
- To examine cyclin D1 expression in HCC tissues.
- To determine the relationship between cyclin D1, p53, and Ki-67 expression.
- To assess the clinical significance of cyclin D1 in hepatocarcinogenesis.
Main Methods:
- Immunohistochemical analysis of cyclin D1, p53, and Ki-67 expression in 50 HCC cases.
- Evaluation of protein distribution and correlation with pathological features.
- Investigation of relationships between protein expressions and clinicopathological parameters.
Main Results:
- Cyclin D1 overexpression was found in 58% of HCC cases, associated with well-differentiated histology and low Ki-67.
- Aberrant p53 expression (36% of cases) correlated with poor differentiation and high Ki-67.
- No significant correlation was observed between cyclin D1 and p53 expression.
Conclusions:
- Cyclin D1 overexpression may be an early event in hepatocarcinogenesis.
- Cyclin D1 plays a role in tumor differentiation in HCC.
- Cyclin D1 expression is not correlated with tumor cell proliferation in HCC.